AI-Agent for Automated Diagnosis and Predicting Using EHR and Multimodal Data
Launched by THE EYE HOSPITAL OF WENZHOU MEDICAL UNIVERSITY · Jan 19, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of an AI agent to help doctors diagnose diseases and predict health outcomes by analyzing electronic health records (EHR) and various medical images like X-rays, CT scans, and MRIs. The goal is to see if this advanced technology can make it easier and more accurate for healthcare providers to understand patient health and make better treatment decisions.
To participate in the trial, individuals must have detailed electronic health records and relevant imaging data related to their health conditions. It's important that participants have a confirmed diagnosis of a disease or health issue. Patients will need to agree to allow their past health information to be used for research. If a patient's diagnosis is unclear or if there are duplicate records, they won't be eligible. Those who join the study can expect their health data to be used to improve how AI can support medical care in the future. The trial is currently looking for participants of all ages and genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Participants must have comprehensive electronic health records (EHR) available, including demographic information, medical history, and laboratory results.
- • 2. Participants must have available multimodal imaging data (e.g., X-rays, CT scans, MRIs, ultrasounds) relevant to their health condition.
- • 3. Participants must have a confirmed diagnosis of one or more diseases or health conditions based on clinical records or imaging data.
- • 4. Patients must provide consent for the use of their historical health data for research purposes.
- Exclusion Criteria:
- • 1. Participants with ambiguous or unverifiable diagnoses that cannot be accurately categorized.
- • 2. Duplicate or redundant patient data (e.g., repeated records of the same patient without clear differentiation).
About The Eye Hospital Of Wenzhou Medical University
The Eye Hospital of Wenzhou Medical University is a leading clinical research institution dedicated to advancing ophthalmic care through innovative studies and trials. Renowned for its commitment to excellence in eye health, the hospital integrates cutting-edge research with clinical practice, focusing on a wide range of ocular diseases and treatments. With a team of highly skilled professionals and state-of-the-art facilities, the Eye Hospital aims to enhance patient outcomes and contribute to the global understanding of ophthalmology through rigorous clinical trials and collaborative research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chengdu, Sichuan, China
Guangzhou, Guangdong, China
Guangzhou, Guangdong, China
Wenzhou, Zhejiang, China
Guangzhou, Guangdong, China
Wenzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported